SRTA — Strata Critical Medical, Inc. stock price, charts and financials

NASDAQ·Healthcare·Medical - Care Facilities·USA

Latest market price

5.84

+0.05+0.86%

Overview Short InterestFilings

SRTAQT78Strata Critical Medical, Inc.·NASDAQ

Overview Short InterestFilings

5.84+0.86%

Loading chart...

Signal & projected range

QT Score upgradeHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

TOI-19.72%$5.13 GMRS+0.24%$12.61 CYH-2.83%$2.92 AUNA-0.56%$5.29 VMD-3.03%$9.44 AIRS-48.50%$2.58 TALK+0.29%$5.24 NUTX+19.46%$193.60

Snapshot

Index	-	P/E	-	EPS (ttm)	-0.16	Insider Own	28.49%	Shs Outstand	86.53M	Perf Week	15.34%

Market Cap	500.99M	Forward P/E	-	EPS next Y	0.00	Insider Trans	-0.55%	Shs Float	45.00M	Perf Month	12.87%

Enterprise Value	488.93M	PEG	0.70	EPS next Q	-	Inst Own	-	Short Float	9.62%	Perf Quarter	8.43%

Income	40.38M	P/S	1.96	EPS this Y	42.19%	Inst Trans	-	Short Ratio	3.96	Perf Half Y	31.59%

Sales	255.97M	P/B	1.79	EPS next Y	103.60%	ROA	12.09%	Short Interest	4.33M	Perf YTD	20.37%

Book/sh	-	P/C	-	EPS next 5Y	-	ROE	14.27%	52W High	6.56 -10.92%	Perf Year	49.61%

Cash/sh	-	P/FCF	-	EPS past 3/5Y	-	ROIC	-7.09%	52W Low	3.71 57.34%	Perf 3Y	45.66%

Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	10.50% 53.66%	Gross Margin	20.56%	Volatility	8.06% 4.77%	Perf 5Y	-24.51%

Dividend TTM	-	EV/Sales	1.91	EPS Y/Y TTM	54.29%	Oper. Margin	-7.97%	ATR (14)	0.29	Perf 10Y	-

Dividend Ex-Date	-	Quick Ratio	2.64	Sales Y/Y TTM	2.01%	Profit Margin	15.71%	RSI (14)	60.77	Recom	2.00

Dividend Gr. 3/5Y	-	Current Ratio	2.64	EPS Q/Q	-	SMA20	10.20%	Beta	2.25	Target Price	7.25

Payout	0.00%	Debt/Eq	0.02	Sales Q/Q	24.07%	SMA50	5.47%	Rel Volume	1.10	Prev Close	5.79

Employees	601	LT Debt/Eq	0.01	Earnings	Nov 09	SMA200	15.88%	Avg Volume	1.20M	Price	5.84

IPO Date	Nov 05, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	180.00% 5.82%	Net Debt/EBITDA	1.29	Volume	1,314,675	Change	0.86%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Sep-17-25	Reiterated	Lake Street	Buy	$7.25

Latest News

Aug-06-26

Aug-06-2601:21PM

Can Strata Critical Medical, Inc. (SRTA) Run Higher on Rising Earnings Estimates?zacks.com

Aug-05-26

Aug-05-2611:40AM

Strata Critical Medical, Inc. 2026 Q2 - Results - Earnings Call PresentationSeekingAlpha

Aug-04-26

Aug-04-2610:56AM

Wall Street Analysts Predict a 60% Upside in Strata Critical Medical, Inc. (SRTA): Here's What You Should Knowzacks.com

10:49AM

Strata Critical Medical, Inc. (SRTA) Q2 2026 Earnings Call Transcriptseekingalpha.com

07:00AM

Strata Critical Medical Announces Second Quarter 2026 Resultsglobenewswire.com

Jul-21-26

Jul-21-2604:05PM

Strata Critical Medical Schedules Second Quarter 2026 Earnings Conference Callglobenewswire.com

Jul-07-26

Jul-07-2608:15AM

Strata Critical Medical: A Better Alternative To TransMedics In Organ Transplant LogisticsSeekingAlpha

Jun-24-26

Jun-24-2609:01AM

Strata Critical Medical Acquires Heart And Lung Transplant National Recovery Program For $21.5MBenzinga

Company

Strata Critical Medical, Inc. is dedicated to supporting healthcare providers throughout the United States by offering swift logistical management and specialized medical assistance. A significant part of their operations involves the movement of human organs for transplant, utilizing both aerial and ground transportation methods. Founded in 2014, the organization previously operated under the name Blade Air Mobility, Inc. and is set to officially change its name to Strata Critical Medical, Inc. in August of 2025. Its primary corporate office is located in New York, New York.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 9/30/2021	FY 2020 9/30/2020	FY 2019 9/30/2019
Total Revenue	256	197	249	—	—	—	—	—
Cost of Goods Sold Incl. D&A	203	156	190	—	—	—	—	—
Gross Profit	53	41	59	—	—	—	—	—
Selling, General and Administrative Excl. Other	59	61	90	—	—	—	—	—
Research and Development	0	3	3	—	—	—	—	—
Other Operating Expense	14	-1	0	—	—	—	—	—
Operating Income	-20	-22	-34	—	—	—	—	—
Interest Expense	0	0	0	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	-3	2	6	—	—	—	—	—
Net Income Before Taxes	-24	-20	-28	—	—	—	—	—
Income Taxes	0	0	0	—	—	—	—	—
Consolidated Net Income	39	41	-27	—	—	—	—	—
Net Income From Continuing Operations	-24	-20	-27	—	—	—	—	—
Net Income	39	41	-27	—	—	—	—	—
EPS (Recurring)	-0.24	-0.19	-0.35	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	-0.24	-0.19	-0.35	—	—	—	—	—
EPS (Diluted)	-0.24	-0.19	-0.35	—	—	—	—	—
EBITDA	-10	-6	-22	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—
Price To Earnings Ratio	—	—	—	—	—	—	—	—
Price To Sales Ratio	1.96	2.00	1.31	—	—	—	—	—
Gross Margin	20.70	20.81	23.69	—	—	—	—	—
Operating Margin	-7.81	-11.17	-13.65	—	—	—	—	—
Net Margin	15.23	20.81	-10.84	—	—	—	—	—
Shares Outstanding	86	82	77	—	—	—	—	—
Market Capitalization	502	394	327	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wunsch Scott M	CEO, Logistics	Jun 08 '26	Sale	5.87	5,550	32,579	625,574	Jun 10
Heyburn William A.	Co-CEO and CFO	Jun 08 '26	Sale	5.87	31,671	185,909	1,548,997	Jun 10
Cohen Amir	Chief Accounting Officer	Jun 08 '26	Sale	5.87	4,655	27,325	146,608	Jun 10
Tomkiel Melissa M.	Co-CEO and General Counsel	Jun 08 '26	Sale	5.87	29,730	174,515	1,892,774	Jun 10
Cohen Amir	Chief Accounting Officer	May 22 '26	Sale	5.91	40,575	239,798	151,263	May 26
Cohen Amir	Chief Accounting Officer	May 21 '26	Sale	5.79	10,300	59,637	191,838	May 26
Cohen Amir	Chief Accounting Officer	May 11 '26	Sale	5.79	14,306	82,832	202,138	May 13
Tomkiel Melissa M.	Co-CEO and General Counsel	Jan 02 '26	Option Exercise	0.18	276,960	49,853	1,643,362	Jan 05
Heyburn William A.	Co-CEO and CFO	Dec 09 '25	Buy	4.47	17,000	76,044	1,403,436	Dec 10
LAUCK ANDREW	Director	Dec 05 '25	Buy	4.37	5,000	21,825	135,642	Dec 05
Love Reginald	Director	Nov 20 '25	Sale	4.37	11,000	48,070	113,897	Nov 24
Love Reginald	Director	Nov 19 '25	Sale	4.31	11,000	47,434	124,897	Nov 20
Tomkiel Melissa M.	Co-CEO and General Counsel	Nov 07 '25	Option Exercise	0.18	27,778	5,000	1,400,420	Nov 12
Tomkiel Melissa M.	Co-CEO and General Counsel	Oct 22 '25	Option Exercise	0.18	55,556	10,000	1,270,372	Oct 23
Tomkiel Melissa M.	Co-CEO and General Counsel	Oct 10 '25	Option Exercise	0.18	55,555	10,000	1,214,816	Oct 14

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.